NASDAQ : FTH
Faeth Therapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 18.75 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 484.51M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 18.82M | 11.33M | 13.04M | 18.77M | 19.80M | 15.82M |
| Research & Development | 17.94M | 10.96M | 18.63M | 18.30M | 30.38M | 21.66M |
| Operating Expenses | 36.76M | 22.29M | 31.66M | 37.06M | 50.19M | 37.48M |
| Operating Income | -36.76M | -22.29M | -31.66M | -37.06M | -50.19M | -37.48M |
| Interest Expense | -32.00K | -32.00K | -90.00K | -144.00K | -219.00K | -670.00K |
| Interest & Investment Income | 3.19M | 1.24M | 2.55M | 3.62M | 1.78M | 800.00K |
| Other Non Operating Income (Expenses) | -1.22M | -702.00K | -989.00K | -1.27M | 252.00K | 606.00K |
| EBT Excluding Unusual Items | -34.83M | -21.78M | -30.19M | -34.85M | -48.37M | -36.75M |
| Gain (Loss) on Sale of Investments | 1.38M | 699.00K | 986.00K | 1.06M | -216.00K | -615.00K |
| Gain (Loss) on Sale of Assets | -21.00K | -1.00K | -302.00K | |||
| Asset Writedown | -951.00K | |||||
| Other Unusual Items | -15.60M | 567.00K | ||||
| Pretax Income | -195.53M | -21.09M | -30.16M | -34.10M | -48.59M | -36.79M |
| Earnings From Continuing Operations | -21.09M | -30.16M | -34.10M | -48.59M | -36.79M | |
| Net Income | -195.53M | -21.09M | -30.16M | -34.10M | -48.59M | -36.79M |
| Net Income to Common | -195.53M | -21.09M | -30.16M | -34.10M | -48.59M | -36.79M |
| Shares Outstanding (Basic) | 2.37M | 1.26M | 1.26M | 1.40M | 1.54M | 1.39M |
| Shares Outstanding (Diluted) | 2.37M | 1.26M | 1.26M | 1.40M | 1.54M | 1.39M |
| EPS (Basic) | -82.46 | -16.72 | -24.01 | -24.40 | -31.65 | -26.56 |
| EPS (Diluted) | -82.46 | -16.72 | -24.01 | -24.40 | -31.65 | -26.56 |
| Free Cash Flow | -33.86M | -20.47M | -24.82M | -32.20M | -39.35M | -32.28M |
| Free Cash Flow Per Share | -14.28 | -16.23 | -19.76 | -23.04 | -25.63 | -23.30 |
| EBITDA | -36.64M | -22.15M | -30.34M | -35.71M | -48.84M | -36.80M |
| D&A For EBITDA | 123.00K | 139.00K | 1.32M | 1.35M | 1.35M | 685.00K |
| EBIT | -36.76M | -22.29M | -31.66M | -37.06M | -50.19M | -37.48M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 26.90M | 8.67M | 9.99M | 13.01M | 17.80M | 7.16M |
| Short-Term Investments | 159.54M | 12.52M | 31.34M | 52.75M | 89.32M | 140.46M |
| Cash & Short-Term Investments | 186.44M | 21.18M | 41.34M | 65.76M | 107.12M | 147.62M |
| Prepaid Expenses | 1.36M | 231.00K | 474.00K | 1.17M | 1.13M | 547.00K |
| Other Current Assets | 858.00K | 92.00K | 120.00K | 325.00K | 344.00K | 374.00K |
| Total Current Assets | 188.66M | 21.51M | 41.93M | 67.25M | 108.59M | 148.54M |
| Property, Plant & Equipment | 568.00K | 1.38M | 3.38M | 7.04M | 9.72M | 4.64M |
| Other Long-Term Assets | 80.00K | 18.00K | 48.00K | 86.00K | 63.00K | 39.00K |
| Total Assets | 189.31M | 22.90M | 45.36M | 74.37M | 118.38M | 153.22M |
| Accounts Payable | 2.15M | 689.00K | 244.00K | 573.00K | 4.47M | 2.46M |
| Accrued Expenses | 6.67M | 2.04M | 2.73M | 2.41M | 2.46M | 1.75M |
| Current Portion of Leases | 592.00K | 1.45M | 2.32M | 2.44M | 2.13M | 680.00K |
| Other Current Liabilities | 175.00K | 77.00K | 157.00K | 221.00K | ||
| Total Current Liabilities | 9.58M | 4.25M | 5.45M | 5.64M | 9.07M | 4.89M |
| Long-Term Leases | 59.00K | 1.53M | 3.77M | 5.90M | 1.67M | |
| Other Long-Term Liabilities | 6.77M | 67.00K | 149.00K | |||
| Total Liabilities | 16.35M | 4.31M | 6.97M | 9.48M | 14.97M | 6.71M |
| Common Stock | 2.00K | 3.00K | 3.00K | 3.00K | ||
| Additional Paid-In Capital | 642.40M | 301.73M | 300.45M | 297.00M | 302.20M | 296.05M |
| Retained Earnings | -469.38M | -283.14M | -262.05M | -231.90M | -197.79M | -149.21M |
| Comprehensive Income & Other | -63.00K | 1.00K | -13.00K | -209.00K | -1.00M | -333.00K |
| Total Common Equity | 172.96M | 18.59M | 38.39M | 64.89M | 103.41M | 146.51M |
| Shareholders' Equity | 172.96M | 18.59M | 38.39M | 64.89M | 103.41M | 146.51M |
| Total Liabilities & Equity | 189.31M | 22.90M | 45.36M | 74.37M | 118.38M | 153.22M |
| Total Debt | 592.00K | 1.51M | 3.85M | 6.21M | 8.03M | 2.35M |
| Net Cash (Debt) | 185.85M | 19.68M | 37.49M | 59.55M | 99.08M | 145.27M |
| Net Cash Per Share | 78.38 | 15.61 | 29.85 | 42.61 | 64.54 | 104.85 |
| Filing Date Shares Outstanding | 25.84M | 1.34M | 1.26M | 1.25M | 1.55M | 1.53M |
| Total Common Shares Outstanding | 25.83M | 1.26M | 1.26M | 1.25M | 1.54M | 1.53M |
| Working Capital | 179.08M | 17.26M | 36.48M | 61.61M | 99.52M | 143.65M |
| Book Value Per Share | 6.70 | 14.74 | 30.49 | 51.85 | 67.23 | 95.73 |
| Tangible Book Value | 172.96M | 18.59M | 38.39M | 64.89M | 103.41M | 146.51M |
| Tangible Book Value Per Share | 6.70 | 14.74 | 30.49 | 51.85 | 67.23 | 95.73 |
| Machinery | 397.00K | 369.00K | 1.66M | 2.64M | 3.24M | 5.58M |
| Leasehold Improvements | 253.00K | 253.00K | 253.00K | 253.00K | 253.00K | 253.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -195.53M | -21.09M | -30.16M | -34.10M | -48.59M | -36.79M |
| Depreciation & Amortization | 123.00K | 139.00K | 1.32M | 1.35M | 1.35M | 685.00K |
| Loss (Gain) From Sale of Assets | -20.00K | 302.00K | -15.00K | -29.00K | ||
| Asset Writedown & Restructuring Costs | 132.96M | 951.00K | ||||
| Loss (Gain) From Sale of Investments | -1.38M | -699.00K | -986.00K | -1.06M | 216.00K | 615.00K |
| Stock-Based Compensation | 17.93M | 1.27M | 3.13M | 4.45M | 5.81M | 5.66M |
| Other Operating Activities | 1.51M | 1.51M | 1.55M | 1.36M | 1.19M | -510.00K |
| Change in Accounts Payable | 593.00K | 233.00K | -445.00K | -2.33M | 2.02M | -1.43M |
| Change in Other Net Operating Assets | 9.96M | -1.82M | -44.00K | -2.00M | -1.01M | 1.54M |
| Operating Cash Flow | -33.86M | -20.45M | -24.67M | -32.02M | -39.03M | -30.26M |
| Capital Expenditures | -6.00K | -16.00K | -146.00K | -180.00K | -321.00K | -2.03M |
| Sale of Property, Plant & Equipment | 250.00K | 166.00K | 15.00K | 318.00K | ||
| Cash Acquisitions | 6.46M | |||||
| Investment in Securities | -142.14M | 19.54M | 22.59M | 38.43M | 50.26M | -141.41M |
| Investing Cash Flow | -135.68M | 19.77M | 22.44M | 38.41M | 49.95M | -143.12M |
| Long-Term Debt Repaid | -790.00K | -811.00K | -761.00K | -629.00K | -255.00K | |
| Net Debt Issued (Repaid) | -345.00K | -790.00K | -811.00K | -761.00K | -629.00K | -255.00K |
| Issuance of Common Stock | 1.13M | 7.00K | 34.00K | 48.00K | 342.00K | 140.70M |
| Repurchase of Common Stock | -1.00K | -4.00K | -10.00K | -10.46M | ||
| Other Financing Activities | -16.91M | 142.00K | ||||
| Financing Cash Flow | 183.88M | -645.00K | -787.00K | -11.17M | -287.00K | 163.94M |
| Net Cash Flow | 14.35M | -1.33M | -3.02M | -4.78M | 10.64M | -9.44M |
| Free Cash Flow | -33.86M | -20.47M | -24.82M | -32.20M | -39.35M | -32.28M |
| Free Cash Flow Per Share | -14.28 | -16.23 | -19.76 | -23.04 | -25.63 | -23.30 |
| Levered Free Cash Flow | 855.12K | -12.61M | -14.71M | -21.38M | -22.49M | -17.56M |
| Unlevered Free Cash Flow | 875.12K | -12.59M | -14.65M | -21.29M | -22.36M | -17.14M |
| Change in Working Capital | 10.55M | -1.59M | -489.00K | -4.33M | 1.01M | 117.00K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 482.96M | 13.46M | 12.33M | 17.30M | 45.77M | 177.46M |
| Enterprise Value | 297.11M | -9.56M | -30.21M | -47.94M | -62.39M | 21.70M |
| Last Close Price | 18.69 | 10.67 | 9.80 | 13.84 | 29.80 | 116.00 |
| PB Ratio | 2.79 | 0.72 | 0.32 | 0.27 | 0.44 | 1.21 |
| P/TBV Ratio | 2.79 | 0.72 | 0.32 | 0.27 | 0.44 | 1.21 |
| Debt / Equity Ratio | 0.00 | 0.08 | 0.10 | 0.10 | 0.08 | 0.02 |
| Net Debt / Equity Ratio | -1.07 | -1.06 | -0.98 | -0.92 | -0.96 | -0.99 |
| Net Debt / EBITDA Ratio | 5.07 | 0.89 | 1.24 | 1.67 | 2.03 | 3.95 |
| Net Debt / FCF Ratio | 5.49 | 0.96 | 1.51 | 1.85 | 2.52 | 4.50 |
| Quick Ratio | 19.46 | 4.98 | 7.59 | 11.65 | 11.81 | 30.20 |
| Current Ratio | 19.69 | 5.06 | 7.70 | 11.92 | 11.98 | 30.38 |
| Return on Equity (ROE) | -195.26% | -74.01% | -58.40% | -40.52% | -38.88% | -45.31% |
| Return on Assets (ROA) | -20.79% | -40.81% | -33.05% | -24.04% | -23.10% | -26.83% |
| Return on Capital Employed (ROCE) | -20.50% | -119.50% | -79.30% | -53.90% | -45.90% | -25.30% |
| Earnings Yield | -441.19% | -156.67% | -244.65% | -197.14% | -106.15% | -20.73% |
| FCF Yield | -7.01% | -152.10% | -201.32% | -186.17% | -85.96% | -18.19% |
| Buyback Yield / Dilution | -88.34% | -0.40% | 10.15% | 8.96% | -10.80% | -1,618.88% |